Brief: TherapeuticsMD Announces Leadership Changes Appointment Of Industry Veteran, Hugh O’Dowd, As CEO
11/11/2021 11:48
Nov 11 (Reuters) - TherapeuticsMD Inc TXMD.O :
* THERAPEUTICSMD ANNOUNCES LEADERSHIP CHANGES; APPOINTMENT
OF
INDUSTRY VETERAN, HUGH O’DOWD, AS CHIEF EXECUTIVE OFFICER
Source text for Eikon: ID:nBw71BSsZa
Further company coverage: TXMD.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on TherapeuticsMD
See all newsBrief: TherapeuticsMD Announces First Quarter 2026 Financial Results
TherapeuticsMD swings to Q1 net income as license revenue rises
TherapeuticsMD swings to Q3 profit, license revenue climbs
Brief: TherapeuticsMD Q1 Operating Expenses USD 1.264 Million
Brief: Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract